Long-term efficacy of infliximab in refractory posterior uveitis of Beh?et's disease: a 24-month follow-up study

摘要

Objectives. To evaluate the long-term efficacy and safety of infliximab in patients with Beh?et's disease (BD) and refractory bilateral posterior uveitis, and to assess the proportion of relapse-free subjects through months 12 and 24.